Rasmus Sejersten Ripa

Rasmus Sejersten Ripa

Postdoc, Clinical Associate Professor

ORCID: 0000-0003-2035-2321

Publication year:
All
1 - 4 out of 4Page size: 10
  1. 2011

  2. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease

    Mathiasen, A. B., Harutyunyan, M. J., Jørgensen, E., Helqvist, S., Ripa, Rasmus Sejersten, Gøtze, J. P., Johansen, J. S. & Kastrup, J., Sep 2011, In: Scandinavian Journal of Clinical & Laboratory Investigation. 71, 5, p. 439-47 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina

    Friis, T., Haack-Sørensen, M., Mathiasen, A. B., Ripa, Rasmus Sejersten, Kristoffersen, U. S., Jørgensen, E., Hansen, L., Bindslev, L., Kjær, A., Hesse, B., Dickmeiss, E. & Kastrup, J., Jun 2011, In: Scandinavian Cardiovascular Journal. 45, 3, p. 161-8 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Granulocyte-Colony Stimulating Factor Therapy to Induce Neovascularization in Ischemic Heart Disease: Doktordisputats.

    Ripa, Rasmus Sejersten, 2011

    Research output: Book/Report › Doctoral thesis › Research

  5. Published

    The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease

    Mygind, N. D., Harutyunyan, M. J., Mathiasen, A. B., Ripa, Rasmus Sejersten, dmr788, dmr788, Goetze, Jens P. , Johansen, Julia Sidenius, Kastrup, J. & The CLARICOR Trial Group, T. C. T. G., 2011, In: Inflammation Research. 60, 3, p. 281-7 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 45867987